Clinical Trial Update: Cladribine Based Induction Therapy With All-Trans Retinoic Acid and Midostaurin in Relapsed/Refractory AML [Phase 1]

View source ↗

Summary

Phase 1 study investigating cladribine-based induction therapy combined with all-trans retinoic acid and midostaurin for relapsed/refractory acute myeloid leuke…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• All-trans Retinoic Acid (all-trans retinoic acid)
• Cladribine (cladribine)
• Midostaurin (midostaurin)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Leukemia, Myeloid, Acute | Phase 1 | Status: COMPLETED